HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

prenylcysteine

structure in first source

Networked: 7 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Sulfur Compounds: 278
  - Sulfhydryl Compounds: 4168
    - Cysteine: 6760
      - prenylcysteine: 7
  - Sulfur Amino Acids: 221
    - Cysteine: 6760
      - prenylcysteine: 7
Amino Acids, Peptides, and Proteins: 1
- Amino Acids: 30675
  - Sulfur Amino Acids: 221
    - Cysteine: 6760
      - prenylcysteine: 7
  - Neutral Amino Acids: 200
    - Cysteine: 6760
      - prenylcysteine: 7

Experts

1.	Amadio, Patrizia: 1 article (03/2022)
2.	Banfi, Cristina: 1 article (03/2022)
3.	Barbieri, Silvia S: 1 article (03/2022)
4.	Brioschi, Maura: 1 article (03/2022)
5.	Sandrini, Leonardo: 1 article (03/2022)
6.	Zarà, Marta: 1 article (03/2022)
7.	Baetta, R: 1 article (01/2021)
8.	Banfi, C: 1 article (01/2021)
9.	Barbieri, S S: 1 article (01/2021)
10.	Bergman, O: 1 article (01/2021)

Related Diseases

1.	Breast Neoplasms (Breast Cancer) 09/29/1995 - "In studies using MDR1-transfected human breast cancer cells, the acetylated prenylcysteine analogs inhibit P-glycoprotein-mediated drug transport and enhance the steady-state accumulation of [3H]vinblastine, [3H]colchicine, and [3H]taxol. "
2.	Atherosclerosis 01/01/2021 - "Prenylcysteine oxidase 1, an emerging player in atherosclerosis." 02/21/2023 - "We have recently shown that prenylcysteine oxidase 1 (PCYOX1) is a regulator of atherosclerosis-disease mechanisms, which acts through mechanisms not exclusively related to its pro-oxidant activity. " 01/01/2021 - "Here, we provided evidence that the pro-oxidant enzyme Prenylcysteine Oxidase 1 (PCYOX1), in the human atherosclerotic lesions, is both synthesized locally and transported within the subintimal space by proatherogenic lipoproteins accumulating in the arterial wall during atherogenesis. "
3.	Stroke (Strokes) 10/23/2020 - "Baseline stroke severity adjusted regression model showed that changes within 96-hour poststroke in APOF, APOL1, APMAP, APOC4 (apolipoprotein C4), APOM (apolipoprotein M), PCYOX1 (prenylcysteine oxidase 1), PON1, and APOE correlate with stroke recovery scores (R2=0.38-0.73, adjusted P<0.05). "
4.	Thrombosis (Thrombus) 03/04/2022 - "Prenylcysteine Oxidase 1 (PCYOX1), a New Player in Thrombosis."
5.	Parkinson Disease (Parkinson's Disease) 12/01/2003 - "We previously showed that S-adenosylmethionine (SAM) induces movement impairments similar to those observed in Parkinson's disease (PD) apparently by prenylated protein methylation; 5 kDa molecules being methylated and the symptoms being inhibited by prenylcysteine (PC) analogs. "

Related Drugs and Biologics

1.	Member 1 Subfamily B ATP Binding Cassette Transporter
2.	Paclitaxel (Taxol)
3.	Vinblastine (Vinblastine Sulfate)
4.	Colchicine
5.	Oxidoreductases (Dehydrogenase)
6.	Reactive Oxygen Species (Oxygen Radicals)
7.	Proteins (Proteins, Gene)
8.	Interleukin-1beta (Interleukin 1 beta)
9.	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)
10.	Prokaryotic Initiation Factor-3